Total Payments
$4,544
2024 Payments
$1,056
Companies
38
Transactions
254
Medicare Patients
645
Medicare Billing
$75,510
Payment Breakdown by Category
Food & Beverage$4,451 (97.9%)
Education$49.69 (1.1%)
Travel$43.75 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,451 | 247 | 97.9% |
| Education | $49.69 | 6 | 1.1% |
| Travel and Lodging | $43.75 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $699.82 | 34 | $0 (2024) |
| Indivior Inc. | $545.27 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $488.22 | 28 | $0 (2024) |
| PFIZER INC. | $456.49 | 41 | $0 (2024) |
| ABBVIE INC. | $215.13 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $202.45 | 9 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $153.95 | 5 | $0 (2023) |
| Amarin Pharma Inc. | $148.81 | 6 | $0 (2019) |
| BioDelivery Sciences International, Inc. | $138.61 | 23 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $124.40 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,056 | 48 | Indivior Inc. ($156.01) |
| 2023 | $815.72 | 41 | GlaxoSmithKline, LLC. ($190.03) |
| 2022 | $540.98 | 24 | AstraZeneca Pharmaceuticals LP ($130.07) |
| 2021 | $240.76 | 10 | GlaxoSmithKline, LLC. ($167.69) |
| 2020 | $11.68 | 1 | AstraZeneca Pharmaceuticals LP ($11.68) |
| 2019 | $855.71 | 58 | Amarin Pharma Inc. ($148.81) |
| 2018 | $567.10 | 46 | BioDelivery Sciences International, Inc. ($138.61) |
| 2017 | $456.85 | 26 | GlaxoSmithKline, LLC. ($112.56) |
All Payment Transactions
254 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: NEUROLOGY | ||||||
| 11/23/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $43.49 | General |
| Category: OUD | ||||||
| 11/19/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: OUD | ||||||
| 11/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $38.87 | General |
| Category: HIV | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: VACCINE | ||||||
| 10/08/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: OUD | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Obesity | ||||||
| 09/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $32.49 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/04/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: ANTIBIOTIC | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Obesity | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 174 | 379 | $72,303 | $24,425 |
| 2021 | 7 | 178 | 392 | $47,957 | $24,378 |
| 2020 | 11 | 293 | 577 | $65,750 | $26,707 |
Total Patients
645
Total Services
1,348
Medicare Billing
$75,510
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 116 | $33,872 | $11,034 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 110 | $22,660 | $7,358 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $10,728 | $4,726 | 44.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 22 | 30 | $3,840 | $819.18 | 21.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 18 | 33 | $825.00 | $314.16 | 38.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 20 | 54 | $378.00 | $173.34 | 45.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 121 | $22,990 | $10,335 | 45.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 132 | $15,840 | $8,634 | 54.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 30 | 30 | $4,800 | $4,138 | 86.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 11 | 67 | $2,680 | $844.20 | 31.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 13 | 13 | $442.00 | $254.15 | 57.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 13 | 14 | $980.00 | $135.94 | 13.9% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 15 | 15 | $225.00 | $36.72 | 16.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 220 | $41,800 | $15,764 | 37.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 102 | $11,960 | $5,201 | 43.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 24 | 24 | $3,840 | $2,911 | 75.8% |
| 80305 | Testing for presence of drug | Office | 2020 | 15 | 76 | $3,040 | $952.10 | 31.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2020 | 38 | 38 | $1,292 | $725.42 | 56.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 22 | 22 | $748.00 | $420.64 | 56.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 19 | 20 | $600.00 | $351.90 | 58.6% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 20 | 27 | $1,890 | $261.22 | 13.8% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 15 | 22 | $355.00 | $86.06 | 24.2% |
| 81003 | Automated urinalysis test | Office | 2020 | 14 | 15 | $225.00 | $33.60 | 14.9% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 11 | 11 | $0.11 | $0.11 | 100.0% |
About Dr. Daniel Collins, MD
Dr. Daniel Collins, MD is a Family Medicine healthcare provider based in Coventry, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104874320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Collins, MD has received a total of $4,544 in payments from pharmaceutical and medical device companies, with $1,056 received in 2024. These payments were reported across 254 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,451).
As a Medicare-enrolled provider, Collins has provided services to 645 Medicare beneficiaries, totaling 1,348 services with total Medicare billing of $75,510. Data is available for 3 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Coventry, RI
- Active Since 05/04/2006
- Last Updated 05/31/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104874320
Products in Payments
- TRELEGY ELLIPTA (Drug) $537.25
- SUBLOCADE (Drug) $491.91
- FARXIGA (Drug) $282.71
- XIFAXAN (Drug) $216.22
- UBRELVY (Drug) $215.13
- CHANTIX (Drug) $157.26
- HETLIOZ (Drug) $153.95
- Vascepa (Drug) $148.81
- BUNAVAIL 2.1 mg 30-count box (Drug) $138.61
- PAXLOVID (Drug) $125.06
- ELIQUIS (Drug) $124.40
- INSPIRE (Device) $106.49
- Lucemyra/Lofexidine (Drug) $101.94
- Cologuard Collection Kit (Device) $86.60
- Xofluza (Drug) $82.07
- NURTEC ODT (Drug) $76.73
- INCRUSE (Drug) $70.86
- BREZTRI (Drug) $67.84
- Wegovy (Drug) $63.44
- Otezla (Drug) $61.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Coventry
Elena Kwetkowski, D.o, D.O
Family Medicine — Payments: $1,454
Family Medicine $1,454
David Edelheit, M.d, M.D
Family Medicine — Payments: $25.55
Family Medicine $25.55
Mrs. Ann Avery, Msn, MSN
Family Medicine
Family Medicine
Arleen Sergis, D.o, D.O
Family Medicine
Family Medicine
Ma. Liza Ann Famador, Md, MD
Family Medicine
Family Medicine
Monica Tawadros
Family Medicine
Family Medicine